Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 1,820 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Autism, Autism Spectrum Disorder
Interventions: MapHabit System (MHS); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Alzheimer Disease
Interventions: TACAD, Alzheimer's Association website; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Colorectal Carcinoma
Interventions: Media Intervention, Survey Administration; Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 50 Years to 75 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Sedentary Behavior, Physical Inactivity
Interventions: MOV'D (Move Often eVery Day), Fitbit Self-Monitoring; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Interventions: MGT-006, Vancomycin hydrochloride, Amoxicillin hydrate/ Fosfomycin calcium hydrate/ Metronidazole; Drug
Lead sponsor: Metagen Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Naples, Florida • Boston, Massachusetts • New York, New York

Conditions: Home Parenteral Nutrition, Short Bowel Syndrome
Interventions: SMOFLipid, Standard therapy; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy Volunteers, Pharmacokinetics of ASP015K
Interventions: ASP015K, Placebo; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Glendale, California

Conditions: Liver Cancer
Interventions: Drug-eluting beads loaded with doxorubicin hydrochloride; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 120 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Depression, Anxiety, Suicidal Ideation
Interventions: Adaptive messaging intervention, Non-personalized messaging intervention, Coaching, Psychoeducational links; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Major Depressive Disorder
Interventions: Low Dose Psilocybin, Placebo, Medium Dose Psilocybin; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Carotid Artery Plaque, Arteriosclerosis, Obesity, Metabolic Syndrome X
Interventions: Rimonabant, Placebo (for Rimonabant); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 55 Years and older
Enrollment: 661 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Acute Otitis Media
Interventions: cefdinir (Omnicef), amoxicillin; Drug
Lead sponsor: Abbott; Industry
Eligibility: 6 Months to 6 Years
Enrollment: 425 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 32
States / cities: Birmingham, Alabama • Montgomery, Alabama • Ozark, Alabama + 28 more

Conditions: Neurodermatitis
Interventions: Dupilumab SAR231893, Placebo, Moisturizers, Low to medium potent topical corticosteroids, Topical calcineurin inhibitors; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 7
States / cities: Fort Smith, Arkansas • Sacramento, California • Pembroke Pines, Florida + 4 more

Conditions: Psychology, Social, Adolescent Behavior
Interventions: Gun handling behavior, Debriefing; Behavioral · Other
Lead sponsor: Ohio State University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 245 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Acute Ischemic Stroke
Interventions: endovascular thrombectomy (EVT), Standarad medical care; Device · Other
Lead sponsor: Dr. Michael D Hill; Other
Eligibility: 18 Years and older
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 20
States / cities: Little Rock, Arkansas • San Francisco, California • Torrance, California + 14 more

Conditions: Adolescent
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 11 Years to 13 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Attitude, Intention
Interventions: Control bar code label, Warning label, Informational campaign poster about added-sugar warning labels; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 99 Years
Enrollment: 2,275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Davis, California

Conditions: Cannabis, Low Back Pain, Neuropathic Pain
Interventions: Placebos, dronabinol, Vaporized Cannabis 3.7% THC/5.6% CBD; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 19 Years to 70 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: HIV, HIV Pre-exposure Prophylaxis
Interventions: MK-8527, Placebo to MK-8527; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 352 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 10
States / cities: North Hollywood, California • San Francisco, California • Hallandale, Florida + 7 more

Conditions: Hereditary Leiomyomatosis and Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Sporadic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8
Interventions: Atezolizumab, Bevacizumab, Biopsy Procedure, Biospecimen Collection, Bone Scan, Computed Tomography, Computed Tomography with Contrast, Erlotinib, Magnetic Resonance Imaging, Positron Emission Tomography, Sodium Fluoride F-18; Biological · Procedure · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 12 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 13
States / cities: La Jolla, California • Atlanta, Georgia • Chicago, Illinois + 7 more

Conditions: Rotator Cuff Injuries, Cryotherapy Effect
Interventions: Cryo-compression, Cryo-therapy; Device · Other
Lead sponsor: Allina Health System; Other
Eligibility: 18 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Plymouth, Minnesota

Conditions: Arthritis, Rheumatoid
Interventions: peficitinib, Placebo, methotrexate; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 18 Years and older
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 19
States / cities: Birmingham, Alabama • Huntington Beach, California • La Jolla, California + 16 more

Conditions: Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8
Interventions: Biospecimen Collection, Contrast Agent, Leuprolide, Magnetic Resonance Imaging, Physical Performance Testing, Relugolix; Procedure · Other · Drug
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Colorectal Carcinoma
Interventions: Media Intervention, Best Practice, Questionnaire Administration; Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Evaluating the Feasibility of Collecting User Interaction Data at the Emory Autism Center Using MapHabit Software

TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease

Cancer Communication Within Hispanic Social Networks

Peer Motivation Coaches, Social Media-based Support Group, and Behavior Change Strategies to Decrease Prolonged Sitting and Increase Moderate Exercise Snacks

Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)

SMOFLipid in Patients Who Are Intralipid Intolerant

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects

Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Digital Mental Health Service for Non-Treatment Seeking Young Adults

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant

A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)

Follow-up Gun Study: Can Safety Videos Mitigate Interest in Guns in Children?

EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

Media-Smart Youth Program Evaluation Study

Evaluation of a Beverage Media Campaign and Added-sugar Warning Labels

Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Utility of Intermittent Cryo-Compression Versus Traditional Icing Following Arthroscopic Rotator Cuff Repair

A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test